Current Duke Appointments & Affiliations
Biostatistician III
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia (SILDI-SAFE): A Randomized Controlled Trial.
Journal article J Pediatr · May 7, 2026 OBJECTIVE: To describe the safety of sildenafil based on hypotension in premature infants with bronchopulmonary dysplasia (BPD). STUDY DESIGN: We conducted a multicenter, randomized, double-blind, placebo-controlled, dose-escalating trial of sildenafil. In ... Full text Link to item CitePromoting teaching and non-teaching school staff resilience post-COVID pandemic.
Journal article Ment Health Prev · June 2025 OBJECTIVE: School-based professional development interventions are hopeful mechanisms for promoting teacher/staff mental health and resilience. This study aimed to examine changes in key contributors to mental health and resilience of North Carolina (Unite ... Full text Link to item CiteRisk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry.
Conference J Soc Cardiovasc Angiogr Interv · February 2024 BACKGROUND: Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor before coronary angiography. METHODS: Cangrelor in Acute MI: Effectiveness and Outcomes ... Full text Link to item CiteRecent Grants
Legacy Effects of CALERIE, a 2-year Calorie Restriction Intervention, on Hallmarks of Healthspan and Aging
ResearchStatistician · Awarded by Tufts Medical Center · 2022 - 2027RADx-UP CDCC
ResearchStatistician · Awarded by National Institutes of Health · 2020 - 2025View All Grants